CD19 Expressing Malignancies
1 clinical trials · Condition
◉ Watch CD19 Expressing Malignancies
| Record | Firm | Date |
|---|---|---|
| Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies (NCT04649112) | Precision BioSciences, Inc. | 2021-06-16 |
Track CD19 Expressing Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.